| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.086 | 0.5 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |